Encapsulates paclitaxel (PTX), a widely used anticancer drug, within a nanoparticle designed to maximize drug delivery and accumulation in tumors.

Manufactured through a proprietary 16-step nanoprocess to produce biocompatible and biodegradable nanoparticles.

Designed to minimize nonspecific exposure of paclitaxel in the bloodstream and to normal cells.

More than 30 extensive preclinical tests and about 4,000 pages of accumulated data validated the efficacy and safety of ONX-1006.

Demonstrated significantly greater tumor reduction than Abraxane and the highest level of cancer cell death in pancreatic cancer xenograft models.

Established No Observed Adverse Effect Levels (NOAELs) in completed preclinical tests, with no side effects observed.

Water-dispersible formulation in which nanoparticles are uniformly dispersed in water, with a particle size of less than 100 nm, about one thousandth the width of a human hair.
※ A nanometer (nm) is one billionth of a meter (10⁻⁹ m).